FERMA549091

EPCR Monoclonal Antibody (RCR-379), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 FERMA549091-Each-of-1 In Stock ₹ 72,223.50

FERMA549091 - Each of 1

₹ 72,223.50

In Stock

Quantity

1

Base Price: ₹ 72,223.50

GST (18%): ₹ 13,000.23

Total Price: ₹ 85,223.73

Antigen

EPCR

Classification

Monoclonal

Concentration

100 μg/mL

Formulation

PBS with 0.1% BSA and no preservative

Gene Accession No.

Q9UNN8

Gene Symbols

Procr

Immunogen

The monoclonal antibody RCR-379 recognizes human endothelial protein C receptor (EPCR), a highly glycosylated type I transmembrane protein of 221-amino-acids.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human

Form

Liquid

Applications

Flow Cytometry, Functional Assay, Immunohistochemistry (Frozen)

Clone

RCR-379

Conjugate

Unconjugated

Gene

Procr

Gene Alias

Activated protein C receptor; AI325044; APC receptor; bA42O4.2; CCCA; CCD41; CD antigen CD201; CD201; CD201 antigen; cell cycle, centrosome-associated protein; centrocyclin; Centrosomal protein CCD41; endothelial cell protein C receptor; Endothelial protein C receptor; Epcr; PROCR; protein C receptor; protein C receptor, endothelial

Host Species

Rat

Purification Method

Protein G

Regulatory Status

RUO

Gene ID (Entrez)

10544

Content And Storage

4° C

Isotype

IgG2a

Related Products

Img

Thermo Scientific

FERMA549090

--

Img

Thermo Scientific

FERMA549033

--

Img

Thermo Scientific

FERMA549086

--

Img

Thermo Scientific

FERMA549087

--

Img

Thermo Scientific

FERMA549034

--

Img

Thermo Scientific

MA181870

--

Img

Thermo Scientific

MA1932

--

Img

Thermo Scientific

FERMA549098

--

Description

  • The protein encoded by this gene is a receptor for activated protein C, a serine protease activated by and involved in the blood coagulation pathway
  • The encoded protein is an N-glycosylated type I membrane protein that enhances the activation of protein C
  • Mutations in this gene have been associated with venous thromboembolism and myocardial infarction, as well as with late fetal loss during pregnancy.